Abstract
Alzheimer's disease (AD) is an age-related, progressive, neurodegenerative disorder, affecting more than 4 million people in the US and more than 30 million people worldwide [1]. The pathological changes seen in the brain are plaque formations consisting mainly of amyloid beta (Aβ) protein deposits surrounded by neurons containingneurofibrillary tangles. Associated with Aβ-containing senile plaques are reactive microglia and activated microphages producing cytokines like IL-1, IL-6 and TNF-α, as well as acute phase proteins, indicating inflammation [2]. Also associated with the plaque deposition is vascular damage and neuronal loss in the area of hippocampus and frontal cortex, leading to severe memory loss